Tena L. Rosser, MD

Associate Professor of Clinical Neurology and Pediatrics

Image of Tena L. Rosser, MD
Is this your profile? Click to edit

Publications

  • Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments. J Neurooncol. 2025 Aug; 174(1):65-76.. View in PubMed
  • Incontinentia pigmenti. Semin Pediatr Neurol. 2024 10; 51:101156.. View in PubMed
  • Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder. Am J Med Genet A. 2024 05; 194(5):e63524.. View in PubMed
  • Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials. Clin Trials. 2024 02; 21(1):6-17.. View in PubMed
  • Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey. Clin Trials. 2024 02; 21(1):73-84.. View in PubMed
  • A Case of Pediatric Guillain-Barré Syndrome After Respiratory Syncytial Virus Infection. Pediatr Neurol. 2023 09; 146:129-131.. View in PubMed
  • Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clin Trials. 2024 02; 21(1):67-72.. View in PubMed
  • Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy. J Pediatr Orthop. 2023 Aug 01; 43(7):e531-e537.. View in PubMed
  • Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey. Am J Med Genet A. 2022 01; 188(1):71-82.. View in PubMed
  • Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 2021 08 17; 97(7 Suppl 1):S73-S80.. View in PubMed